ArticleCancers2023

Up-Front ASCT Overcomes the Survival Benefit Provided by HDAC-Based Induction Regimens in Mantle Cell Lymphoma: Data from a Real-Life and Long-Term Cohort.

Luís Alberto de Pádua Covas Lage et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.